BG Medicine Appoints Stephen Hall As CFO

(RTTNews) - BG Medicine, Inc. (BGMD) said Thursday that it has appointed Stephen Hall as Executive Vice President, Chief Financial Officer.

Hall will replace Charles Abdalian, who has served as BG Medicine's CFO since October 2012.

Hall most recently held the position of Vice President Finance -- Treasurer, Principal Financial and Chief Accounting Officer at Stemline Therapeutics, a publicly traded clinical stage biopharmaceutical company.

Hall has served as Chief Financial Officer at both life science and medical device companies, including Orthocon, Inc., Helicos BioSciences Corporation, TriPath Imaging, Inc., and Colorado MEDtech.